Table 1.
Phenotype | Characteristic | Males (n= 385; 36.7%) | Females (n= 663; 63.26%) | All subjects |
---|---|---|---|---|
Mild‐Moderate (n= 587) | n = 207 (35.2%) | n = 380 (64.7%) | n = 587 (100%) | |
Age of onset | 10.87 ± 12.41 | 13.8 ± 12.5 | 12.83 ± 12.6 | |
FEV1 (%) | 81 ± 18.8 * | 87.57 ± 16.85 * | 85.26 ± 17.86 * | |
IgE (log) | 2.29 ± 0.6 | 1.97 ± 0.7 | 2.09 ± 0.67 | |
Severe (n= 461) | 178 (38.6%) | 283 (61.3%) | N = 461 (100%) | |
Age of onset | 12.83 ± 15.5 | 14.7 ± 14.66 | 14 ± 15 | |
FEV1 (%) | 63.3 ± 21.27 | 66.21 ± 23.71 | 65 ± 22.81 | |
IgE (log) | 2.27 ± 0.61 | 2.05 ± 0.8 | 2.14 ± 0.73 |